The University of Texas MD Anderson Cancer Center received a $1,408,488 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Social Isolation, Loneliness, and Health Outcomes Among Prostate Cancer Survivors." The award, which runs from September 15, 2024 to September 14, 2027, will support innovative scientific studies to improve health outcomes for military service members, veterans, and the broader public. Through this federal grant, MD Anderson will carry out basic, translational, clinical, and public health cancer research focused on prostate cancer survivorship, with the goal of enhancing understanding of the relationship between social isolation, loneliness, and health outcomes in this population.
Generated 2/25/25, 4:12 AM